Sharon Bio-Medicine Ltd Quarterly Results

Gross Sales

35.77

104.69

112.99

490.34

130.44

Excise Duty

0

0

0

0

0

Net Sales

35.77

104.69

112.99

490.34

130.44

Other Operating Income

0

0

0

0

0

Other Income

37.86

0.67

0.72

1.03

0.21

Total Income

73.63

105.36

113.71

491.37

130.65

Total Expenditure

176.07

153.16

167.78

471.97

166.08

PBIDT

-102.44

-47.79

-54.07

19.4

-35.43

Interest

36.32

17.94

16.72

45.67

13.31

PBDT

-138.76

-65.73

-70.79

-26.27

-48.74

Depreciation

5.01

5.01

5

0

7.69

Minority Interest Before NP

0

0

0

0

0

Tax

9.97

0

0

4.66

0

Deferred Tax

0

0

0

0

0

Reported Profit After Tax

-153.73

-70.74

-75.79

-30.94

-56.43

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

-153.73

-70.74

-75.79

-30.94

-56.43

Extra-ordinary Items

34.71

-50.59

-59.11

0

-33.08

Adjusted Profit After Extra-ordinary item

-188.44

-20.15

-16.68

-30.94

-23.35

EPS (Unit Curr.)

-12.93

-5.95

-5.3

-2.6

-4.74

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

23.79

23.79

23.78

23.79

22.46

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

-286.38

-45.64

-47.85

3.95

-27.16

PBDTM(%)

-387.92

-62.78

-62.65

-5.35

-37.36

PATM(%)

-429.77

-67.57

-67.07

-6.3

-43.26